Stratec Biomedical AG | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
127,950.00
144,860.00
146,886.00
184,911.00
209,764.00
187,820
Cost of Goods Sold (COGS) incl. D&A
-
99,924.00
91,854.00
123,350.00
142,268.00
134,339
Gross Income
-
44,936.00
55,032.00
61,561.00
67,496.00
53,481
SG&A Expense
-
22,130.00
26,731.00
36,828.00
44,159.00
39,157
EBIT
-
22,806.00
28,301.00
-
23,337.00
14,324
Unusual Expense
-
67.00
320.00
307.00
106.00
935
Non Operating Income/Expense
-
1,270.00
1,014.00
682.00
5,425.00
1,254
Interest Expense
-
182.00
155.00
1,002.00
738.00
587
Pretax Income
-
24,054.00
27,173.00
22,846.00
28,027.00
14,090
Income Tax
-
4,286.00
5,089.00
3,349.00
2,392.00
2,980
Consolidated Net Income
15,478.00
19,768.00
22,084.00
19,497.00
25,635.00
11,110
Net Income
15,478.00
19,768.00
22,084.00
19,497.00
25,635.00
11,110
Net Income After Extraordinaries
15,478.00
19,768.00
22,084.00
19,497.00
25,635.00
13,251
Net Income Available to Common
15,478.00
19,768.00
22,084.00
19,497.00
25,635.00
8,969
EPS (Basic)
1.32
1.68
1.87
1.65
2.16
0.75
Basic Shares Outstanding
-
11,769.60
11,810.30
11,851.40
11,881.30
11,939.70
EPS (Diluted)
-
1.67
1.85
1.63
2.14
0.75
Diluted Shares Outstanding
-
11,834.50
11,919.50
11,936.70
11,984.40
12,033.80
EBITDA
22,055.00
30,777.00
32,983.00
35,941.00
42,318.00
34,503
Non-Operating Interest Income
-
227.00
361.00
104.00
109.00
34
About Stratec Biomedical
View Profile
